M Ramachandra
Overview
Explore the profile of M Ramachandra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar B, Babu K, Ramachandra M, Krupavathi C, Swamy B, Sreenivasulu Y, et al.
Data Brief
. 2020 May;
30:105560.
PMID: 32368593
Present dataset aims at the inventory data on preparation of Desertification Status Maps (DSM) for the first time in semi-arid region of Anantapur district in the state of Andhra Pradesh,...
2.
Rajasekhar M, Raju G, Raju R, Ramachandra M, Kumar B
Data Brief
. 2018 Sep;
20:1676-1682.
PMID: 30263919
The data deals with the functions that automatically extracted lineaments from the Cartosat, ASTER and SRTM of Digital Elevation Model (DEM) of different spatial resolutions, in the software ArcGIS 10.4....
3.
Kiran Kumar Y, Mehta S, Ramachandra M
J Biomed Phys Eng
. 2017 Jun;
7(2):143-154.
PMID: 28580336
Background And Objective: Cerebral Arteriovenous Malformation (CAVM) hemodynamic is disease condition, results changes in the flow and pressure level in cerebral blood vessels. Measuring flow and pressure without catheter intervention...
4.
Tervonen T, Belitskin D, Pant S, Englund J, Marques E, Ala-Hongisto H, et al.
Oncogene
. 2015 Jul;
35(14):1832-46.
PMID: 26165838
Hepsin belongs to a family of cell-surface serine proteases, which have sparked interest as therapeutic targets because of the accessibility of extracellular protease domain for inhibitors. Hepsin is frequently amplified...
5.
Ramachandra M, Rahman A, Zou A, Vaillancourt M, Howe J, Antelman D, et al.
Nat Biotechnol
. 2001 Nov;
19(11):1035-41.
PMID: 11689848
Replicating adenoviruses may prove to be effective anticancer agents if they can be engineered to selectively destroy tumor cells. We have constructed a virus (01/PEME) containing a novel regulatory circuit...
6.
Atencio I, Avanzini J, Johnson D, Neuteboom S, Vaillancourt M, Nielsen L, et al.
Mol Ther
. 2001 Jul;
4(1):5-12.
PMID: 11472100
TP53 is the most commonly altered tumor-suppressor gene in cancer and is currently being tested in Phase II/III gene replacement trials. Many tumors contain wild-type TP53 sequence with elevated MDM2...
7.
Ahmed C, Wills K, Sugarman B, Johnson D, Ramachandra M, Nagabhushan T, et al.
J Interferon Cytokine Res
. 2001 Jul;
21(6):399-408.
PMID: 11440637
Replication-deficient adenoviruses expressing human interferon-alpha2b (HuIFN-alpha2b) or the hybrid IFN-alpha2alpha1 or those with the secretory signal deleted, whose express is driven by the alpha-fetoprotein (AFP) promoter, were constructed and characterized....
8.
Rahman A, Tsai V, Goudreau A, Shinoda J, Wen S, Ramachandra M, et al.
Mol Ther
. 2001 May;
3(5 Pt 1):768-78.
PMID: 11356081
Recombinant adenoviral (rAd) vectors are capable of mediating high-efficiency gene transfer in vivo. Under conditions requiring systemic administration, however, the use of rAd vectors can be problematic due to the...
9.
Atencio I, Ramachandra M, Shabram P, Demers G
Cell Growth Differ
. 2000 Jun;
11(5):247-53.
PMID: 10845425
Reports suggest a role of calpains in degradation of wild-type p53, which may regulate p53 induction of apoptosis. A calpain inhibitor, n-acetyl-leu-leu-norleucinal (calpain inhibitor 1), was assessed for ability to...
10.
Lee C, Ramachandra M, Jeang K, Martin M, Pastan I, Gottesman M
FASEB J
. 2000 Mar;
14(3):516-22.
PMID: 10698967
The MDR1 multidrug transporter P-gp (P-glycoprotein) is an efflux pump that extrudes diverse hydrophobic drugs and peptides from cells. Since the entry of HIV-1 into cells involves an initial interaction...